Clinical Trials Directory

Trials / Terminated

TerminatedNCT05140759

An Automated Continual Water Removal System in Patients With Advanced Diuretic Resistant Heart Failure

A Multi-centre, Prospective, Open Label, Uncontrolled Pilot Study to Assess the Feasibility and Tolerability of an Automated Continual Water Removal System in Patients With Advanced Diuretic Resistant Heart Failure

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
3 (actual)
Sponsor
Paragate Medical LTD · Industry
Sex
All
Age
21 Years
Healthy volunteers
Not accepted

Summary

This study will assess the functionality and tolerability of an automated continual water removal system in up to 8 patients with HF and diuretic resistance. intervention: Implanted absorption chamber, connected to an external pump. Follow up: 3 months post activation.

Detailed description

Study Duration: 24 months Enrolment 20 months, Follow-up 3 months, Close-out 1 month Study Centres Up to 4 centres with Medical University Wroclaw, Poland, as the principal site. Objectives: To assess the feasibility, tolerability and functionality of an intra-peritoneal, mechanically induced, ultrafiltration system, through the analysis of procedure and device related serious adverse events and device function. Number of Subjects: Up to 8 Diagnosis and Main Inclusion Criteria: Patients with fluid overloaded congested heart failure (NYHA Class II-IV) with diuretic resistance and a history of multiple heart failure related admissions. Study Product and Planned Use: The Paragate Medical IPUDx System comprises an intraperitoneally implanted fluid absorption chamber with an external wearable rechargeable pump, drainage bag and controller. The system induces isotonic fluid loss across the peritoneal membranes which is collected in the fluid absorption chamber and transported to the external fluid drainage bag. Statistical Methodology: No statistical hypothesis is proposed. Safety will be evaluated using a complete description of Serious Adverse Events. A descriptive analysis will be performed for all primary and secondary variables of the study for the basal measures and all post-basal measures.

Conditions

Interventions

TypeNameDescription
DEVICEautomated continual water removal systemThe device removes excess fluids in heart failure patients with diuretic resistance

Timeline

Start date
2022-02-24
Primary completion
2024-01-17
Completion
2024-01-17
First posted
2021-12-01
Last updated
2024-01-19

Locations

3 sites across 3 countries: Georgia, Israel, Poland

Source: ClinicalTrials.gov record NCT05140759. Inclusion in this directory is not an endorsement.